Precigen (PGEN) Equity Income (2013 - 2022)
Precigen (PGEN) posted quarterly Equity Income of -$9.7 million for Q1 2014, down 510.75% year-over-year from $2.4 million in Q1 2013, and down 510.75% quarter-over-quarter from -$1.6 million in Q1 2013.
Powered by 
Analysis
Precigen (PGEN) Equity Income (2013 - 2022) Analysis & Trends
Precigen (PGEN) has reported Equity Income for 2 consecutive years, with -$9.7 million the latest figure, recorded in Q1 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 4.08 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | 862,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Mar 31, 2021 | -3,000.00 |
| Dec 31, 2020 | -13,000.00 |
| Sep 30, 2020 | -523,000.00 |
| Jun 30, 2020 | -251,000.00 |
| Mar 31, 2020 | -389,000.00 |
| Dec 31, 2019 | -1.70 Mn |
| Sep 30, 2019 | -1.65 Mn |
| Jun 30, 2019 | -1.75 Mn |
| Mar 31, 2019 | -1.64 Mn |
| Dec 31, 2018 | -1.73 Mn |
| Sep 30, 2018 | -2.87 Mn |
| Jun 30, 2018 | -4.55 Mn |
| Mar 31, 2018 | -2.46 Mn |
| Dec 31, 2017 | -3.01 Mn |
| Sep 30, 2017 | -2.99 Mn |
| Jun 30, 2017 | -3.33 Mn |
| Mar 31, 2017 | -4.95 Mn |